Skip to content
Review Open access

Cognitive and Behavioural Profile of SOD1-ALS Across the ALS-FTD Spectrum: A Systematic Review

Sep 2026 · International Journal of Molecular Sciences · Vol 27, pp. 7958 · 0 citations · 46 references
Medicine

TL;DR

It is indicated that cognitive and behavioural involvement can occur in SOD1-ALS, highlighting a highly heterogeneous phenotype.

Abstract

Amyotrophic Lateral Sclerosis (ALS) is increasingly recognized as a multisystem disorder. However, SOD1-associated ALS has traditionally been regarded as an exclusively motor phenotype. This systematic review challenges that paradigm by characterizing the cognitive and behavioural profiles of SOD1 mutation-related ALS. Following PRISMA guidelines, a systematic PubMed search identified 17 eligible studies. Across the included studies, encompassing 222 patients with SOD1 variants, three of the analyzed subjects fulfilled the diagnostic criteria for frontotemporal dementia (FTD), and a larger proportion exhibited multidomain cognitive deficits, including executive dysfunction, language impairment, and working memory decline. Behavioural disturbances, such as apathy, emotional lability, and mental rigidity, were also prominent. The historical assumption that SOD1 mutations completely spare cognitive networks likely reflects an under-recognition of subtle manifestations, compounded by the limited sensitivity of earlier screening tools. These findings indicate that cognitive and behavioural involvement can occur in SOD1-ALS, highlighting a highly heterogeneous phenotype. Encompassing varying degrees of severity—from subtle differences in neuropsychological test scores to formal FTD diagnoses—the current evidence points towards possible variant-specific phenotypes rather than a uniform cognitive syndrome. Routine multidomain cognitive screening is crucial in this population. Properly characterizing these non-motor features allows for more accurate disease staging, better monitoring of clinical progression, and the implementation of truly personalized care strategies.

Read PDF

Similar papers

Open access Sep 2026

Conceptualizing cognition and behaviour across amyotrophic lateral sclerosis and frontotemporal dementia.

Cognitive and behavioral dysfunction in frontotemporal dementia (FTD) evolves along a clinical continuum from a clinically silent stage of disease, through a prodromal period, often referred to as mild cognitive impairment (MCI) and/or mild behavioral impairment (MBI), and into a clinically manifest stage recognized by...

M. Benatar, E. Huey, Chiadikaobi Onyike et al. · 1 citation
Open access Oct 2026

EARLY-ALS: a multicentre study on prodromal amyotrophic lateral sclerosis.

BACKGROUND Neurodegenerative diseases often feature a prolonged phase of subtle changes preceding diagnosis. In amyotrophic lateral sclerosis (ALS), defining this prodromal period is critical for identifying early disease features and intervention windows. METHODS In this case-control study, 475 patients with ALS and...

I. Cordts, A. Galhoz, L. Tzeplaeff et al. · 0 citations
Open access Sep 2026

FRONTOTEMPORAL DEMENTIA - COMPREHENSIVE INSIGHTS INTO PATHOGENESIS, DIAGNOSIS, AND INNOVATIVE TREATMENTS

Frontotemporal dementia (FTD) is a clinically and genetically diverse group of neurodegenerative disorders predominantly affecting the frontal and anterior temporal lobes, leading to progressive changes in behavior, language, and executive function. FTD is the most common cause of young-onset dementia and third overall...

Piotr Wilczkowski, Aleksandra Palka, Natalia Krzysztofek et al. · 0 citations
Open access Oct 2026

A-14: ADHD, Dementia, or Both? Challenges at the Intersection of Neurodevelopment and Neurodegeneration

Objective: Attention-Deficit/Hyperactivity Disorder (ADHD) is associated with functional impairment across the lifespan, as well as comorbidities that may diminish cognitive functioning (e.g., substance use, cardiovascular disease, psychological symptoms). In older adults, these symptoms may complicate accurate detec...

John B. O'Hara · 0 citations
Review Open access Oct 2026

Cognitive Impairment in Drug-Resistant Epilepsy: A Multidomain Systematic Review

Background: Drug-resistant epilepsy (DRE) is frequently accompanied by cognitive impairment across multiple neuropsychological domains. Objectives: We aimed to synthesize contemporary evidence on cognitive impairment, neurobiological correlates, potentially modifiable clinical factors, and treatment-related cognitive o...

Mateusz Bargielski, Edyta Adamska-Patruno, A. Krętowski et al. · 0 citations
Open access Oct 2026

Neuropsychiatric and Cognitive Symptom Evolution over the First Decade of Biomarker-Positive, Sporadic Parkinson's Disease.

BACKGROUND Parkinson's disease (PD) is frequently accompanied by neuropsychiatric symptoms (NPS), including cognitive impairment, which often emerge early and co-occur. Their long-term evolution remains incompletely characterized, particularly in biomarker-positive cohorts. OBJECTIVE The aim was to examine the evolut...

Izabelle Schoen, Jing Wang, Sharon X. Xie et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.